Release Notes: Version 20211209
About this release
This release (version 20211209) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
Manufactured Product (MP)
There is 1 new deprecated concept in this version which was originally created in error.
mp_code | mp_formal_name | mp_fr_description | Type of change |
|---|---|---|---|
| 77700627 | DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC. | DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg par 5 mL solution injectable fiole) TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC. | Concept deprecated |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]